3 unknown, 2 completed. 3 Phase 4, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Completed 1 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Marco Valgimigli: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study Immediate stenting, Delayed stenting - Myocardial Infarction | Phase 4 | Unknown | Marco Valgimigli | 100 | 2011-10-01 | 2011-10-31 |
| Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study Bare metal stent implantation, zotarolimus eluting stent - Coronary Artery Disease | Phase 3 | Unknown | Marco Valgimigli | 1606 | 2011-06-01 | 2012-10-10 |
| Predictive Value of Allen's Test Result in Elective Patients Undergoing Coronary Catheterization Through Radial Approach coronary catheterisation - Coronary Artery Disease | Phase 3 | Completed | Marco Valgimigli | 203 | 2007-10-01 | 2011-10-27 |
| Synergy Between Stent and Drugs to Avoid Ischemic Recurrences After Percutaneous Coronary Intervention clopidogrel treatment after bare metal stent implantation, clopidogrel after zotarolimus-eluting stent implantation, clopidogrel after paclitaxel-eluting stent implantation - Coronary Artery Disease | Phase 4 | Completed | Marco Valgimigli | 1700 | 2006-12-01 | 2012-10-10 |
| Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI abciximab followed by implantation of bare metal stent, abciximab and Sirolimus eluting stent, tirofiban and bare metal stent - Myocardial Infarction | Phase 4 | Unknown | Marco Valgimigli | 744 | 2004-11-01 | 2011-10-27 |
Coronary Artery Disease (3) · Myocardial Infarction (2) · ST Elevation Myocardial Infarction (1)
Abciximab (1) · Drug-Eluting Stents (1) · Purinergic P2Y Receptor Antagonists (1) · Stents (1) · Thienopyridines (1) · Tirofiban (1)
Italy (5) · Hungary (1) · Portugal (1) · Switzerland (1)
Roberto Ferrari, Professor (1)
PMID 18375998, PMID 21095265, PMID 21251631, PMID 22438530, PMID 23315904, PMID 24161321, PMID 24176438, PMID 24332420, PMID 24583305, PMID 25718355, PMID 25720624, PMID 26342472, PMID 26643501, PMID 26965932, PMID 26995375, PMID 27572001, PMID 28605779, PMID 29275371, PMID 35224730